SIRT2 and nasopharyngeal carcinoma: To confirm further the role of SIRT2 in promoting Lapatinib resistance, we next examined if siRNA-depletion of SIRT2 can enhance the antiproliferative effects of Lapatinib in the 5-8F and 6-10B NPC cells using clonogenic assays.